Moderate to Severe Atopic Hand and Foot Dermatitis
1 clinical trials · Condition
◉ Watch Moderate to Severe Atopic Hand and Foot Dermatitis
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Moderate-to-Severe Atopic Hand and Foot Dermatitis (Liberty-AD-HAFT) (NCT04417894) | Regeneron Pharmaceuticals | 2021-04-14 |
Track Moderate to Severe Atopic Hand and Foot Dermatitis automatically
Every clearance here is in the API, with alerts when new ones post.